Teva Pharmaceutical Industries Property, Plant, and Equipment 2010-2024 | TEVA

Teva Pharmaceutical Industries property, plant, and equipment from 2010 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
  • Teva Pharmaceutical Industries property, plant, and equipment for the quarter ending September 30, 2024 was $5.672B, a 0.89% increase year-over-year.
  • Teva Pharmaceutical Industries property, plant, and equipment for 2023 was $5.75B, a 0.19% increase from 2022.
  • Teva Pharmaceutical Industries property, plant, and equipment for 2022 was $5.739B, a 4.06% decline from 2021.
  • Teva Pharmaceutical Industries property, plant, and equipment for 2021 was $5.982B, a 4.99% decline from 2020.
Teva Pharmaceutical Industries Annual Property, Plant, and Equipment
(Millions of US $)
2023 $5,750
2022 $5,739
2021 $5,982
2020 $6,296
2019 $6,436
2018 $6,868
2017 $7,673
2016 $8,073
2015 $6,544
2014 $6,535
2013 $6,635
2012 $6,315
2011 $5,947
2010 $4,357
2009 $3,766
Teva Pharmaceutical Industries Quarterly Property, Plant, and Equipment
(Millions of US $)
2024-09-30 $5,672
2024-06-30 $5,573
2024-03-31 $5,618
2023-12-31 $5,750
2023-09-30 $5,622
2023-06-30 $5,712
2023-03-31 $5,751
2022-12-31 $5,739
2022-09-30 $5,568
2022-06-30 $5,740
2022-03-31 $5,932
2021-12-31 $5,982
2021-09-30 $6,040
2021-06-30 $6,127
2021-03-31 $6,112
2020-12-31 $6,296
2020-09-30 $6,152
2020-06-30 $6,122
2020-03-31 $6,221
2019-12-31 $6,436
2019-09-30 $6,643
2019-06-30 $6,732
2019-03-31 $6,785
2018-12-31 $6,868
2018-09-30 $7,101
2018-06-30 $7,213
2018-03-31 $7,420
2017-12-31 $7,673
2017-09-30 $8,001
2017-06-30 $8,043
2017-03-31 $8,160
2016-12-31 $8,073
2016-09-30 $8,379
2016-06-30 $6,693
2016-03-31 $6,632
2015-12-31 $6,544
2015-09-30 $6,422
2015-06-30 $6,427
2015-03-31 $6,349
2014-12-31 $6,535
2014-09-30 $6,551
2014-06-30 $6,709
2014-03-31 $6,665
2013-12-31 $6,635
2013-09-30 $6,501
2013-06-30 $6,360
2013-03-31 $6,291
2012-12-31 $6,315
2012-09-30 $6,281
2012-06-30 $6,082
2012-03-31 $6,083
2011-12-31 $5,947
2011-09-30 $5,560
2011-06-30 $4,815
2011-03-31 $4,591
2010-12-31 $4,357
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $19.350B $15.846B
Teva Pharmaceutical Industries Limited is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as active pharmaceutical ingredients in North America, Europe, Latin America, India, and Israel. Teva's generic product portfolio includes tablets, capsules, liquids, ointments, creams, liquids, injectables, and inhalants. The company's branded products include Copaxone, Austedo, respiratory products like ProAir and Qvar and Ajovy. Teva operates through three segments, North America, Europe and International Markets, each of which includes generics, specialty and over-the-counter products. Teva acquired Allergan's generics business Actavis Generics. The company also acquired Allergan's Anda Inc. Teva acquired Auspex Pharmaceuticals and Barr. Teva has strengthened its position in Europe through its acquisition of Germany's second largest generics producer, ratiopharm.
Stock Name Country Market Cap PE Ratio
Dr Reddy's Laboratories (RDY) India $11.677B 22.35
BridgeBio Pharma (BBIO) United States $4.392B 0.00
Bausch Health Cos (BHC) Canada $3.009B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.142B 12.88
Supernus Pharmaceuticals (SUPN) United States $1.978B 26.93
Taysha Gene Therapies (TSHA) United States $0.447B 31.14
Personalis (PSNL) United States $0.239B 0.00
Assembly Biosciences (ASMB) United States $0.094B 0.00
Sol-Gel Technologies (SLGL) Israel $0.013B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00